Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
Cara Therapeutics initiates phase II CR845 trial
August 3, 2011
CenterWatch Staff
The CenterWatch Monthly, August 2011
August 1, 2011
CenterWatch Staff
FDA advisory committee recommends REMICADER
July 29, 2011
CenterWatch Staff
FDA approves Wiskott Aldrich gene therapy trial
July 29, 2011
CenterWatch Staff
Micell completes enrollment for DESSOLVE II study
July 29, 2011
CenterWatch Staff
Lutonix enrolls first patient in LEVANT 2 trial
July 29, 2011
CenterWatch Staff
Polaris doses first patient in phase III ADI-PEG 20 trial
July 29, 2011
CenterWatch Staff
Lexicon successfully completes phase I LX1033 trial
July 29, 2011
CenterWatch Staff
CSL, Selexis ink commercial license agreement
July 27, 2011
CenterWatch Staff
Cellectis, Lonza reach milestone with CHO-K1SV GS
July 22, 2011
CenterWatch Staff
Previous
1
2
…
129
130
131
132
133
134
135
136
137
…
166
167
Next
Upcoming Events
02
May
Revisiting the FDA’s Proposed Single IRB Mandate: Navigating Changes and Aligning for Success
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
23
May
Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here